{"product_id":"cst-3162s","title":"CST,  3162S, PDGF Receptor beta Antibody","description":"Polyclonal Antibody for studying PDGFR-b. Validated for Western Blotting. Highly specific and rigorously validated in-house, PDGF Receptor beta Antibody (CST #3162) is ready to ship.\n\n\u003cb\u003eProduct Usage Information\u003c\/b\u003e\nWestern Blotting: 1:1000\n\u003cb\u003eStorage\u003c\/b\u003e\nSupplied in 10 mM sodium HEPES (pH 7.5), 150 mM NaCl, 100 µg\/ml BSA and 50% glycerol. Store at -20°C. Do not aliquot the antibody.\n\u003cb\u003eProtocol\u003c\/b\u003e\nAvailable protocols: Western Blotting\n\u003cb\u003eSpecificity \/ Sensitivity\u003c\/b\u003e\nPDGF Receptor beta Antibody detects endogenous levels of PDGF receptor Î² protein. This antibody does not cross-react with other unrelated proteins. This antibody may cross-react with PDGF receptor Î± when highly overexpressed.\nSpecies Reactivity: Human, Mouse, Rat\n\u003cb\u003eSource \/ Purification\u003c\/b\u003e\nPolyclonal antibodies are produced by immunizing animals with a synthetic peptide corresponding to residues near the carboxy-terminal sequence of human PDGF receptor Î². Antibodies are purified by protein A and peptide affinity chromatography.\n\u003cb\u003eBackground\u003c\/b\u003e\nPlatelet derived growth factor (PDGF) family proteins exist as several disulphide-bonded, dimeric isoforms (PDGF AA, PDGF AB, PDGF BB, PDGF CC, and PDGF DD) that bind in a specific pattern to two closely related receptor tyrosine kinases, PDGF receptor Î± (PDGFRÎ±) and PDGF receptor Î² (PDGFRÎ²). PDGFRÎ± and PDGFRÎ² share 75% to 85% sequence homology between their two intracellular kinase domains, while the kinase insert and carboxy-terminal tail regions display a lower level (27% to 28%) of homology (1). PDGFRÎ± homodimers bind all PDGF isoforms except those containing PDGF D. PDGFRÎ² homodimers bind PDGF BB and DD isoforms, as well as the PDGF AB heterodimer. The heteromeric PDGF receptor Î±\/Î² binds PDGF B, C, and D homodimers, as well as the PDGF AB heterodimer (2). PDGFRÎ± and PDGFRÎ² can each form heterodimers with EGFR, which is also activated by PDGF (3). Various cells differ in the total number of receptors present and in the receptor subunit composition, which may account for responsive differences among cell types to PDGF binding (4). Ligand binding induces receptor dimerization and autophosphorylation, followed by binding and activation of cytoplasmic SH2 domain-containing signal transduction molecules, such as GRB2, Src, GAP, PI3 kinase, PLCÎ³, and NCK. A number of different signaling pathways are initiated by activated PDGF receptors and lead to control of cell growth, actin reorganization, migration, and differentiation (5). Tyr751 in the kinase-insert region of PDGFRÎ² is the docking site for PI3 kinase (6). Phosphorylated pentapeptides derived from Tyr751 of PDGFRÎ² (pTyr751-Val-Pro-Met-Leu) inhibit the association of the carboxy-terminal SH2 domain of the p85 subunit of PI3 kinase with PDGFRÎ² (7). Tyr740 is also required for PDGFRÎ²-mediated PI3 kinase activation (8).\n\u003cb\u003eAlternate Names\u003c\/b\u003e\nActivated tyrosine kinase PDGFRB; Beta platelet-derived growth factor receptor; Beta-type platelet-derived growth factor receptor; CD140 antigen-like family member B; CD140B; IBGC4; IMF1; JTK12; KOGS; NDEL1-PDGFRB; PDGF-R-beta; PDGFR; PDGFR beta; PDGFR-1; PDGFR-beta; PDGFR1; PDGFRB; PENTT; PGFRB; platelet derived growth factor receptor beta; Platelet-derived growth factor receptor 1; Platelet-derived growth factor receptor beta; platelet-derived growth factor receptor, beta polypeptide\n\n\u003cb\u003eSpecification\u003c\/b\u003e\n\nREACTIVITY: H M R\nSENSITIVITY: Endogenous\nMW (kDa): 190\nSOURCE: Rabbit","brand":"CST","offers":[{"title":"Default Title","offer_id":46798074544297,"sku":"3162S","price":0.99,"currency_code":"USD","in_stock":true}],"url":"https:\/\/iright.com\/products\/cst-3162s","provider":"Iright","version":"1.0","type":"link"}